(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on today’s article in The New York Times. “Today’s article from The New York Times fundamentally misconstrues the critical value of pharmacy benefit
America’s employers are increasingly highlighting the value that pharmacy benefit managers (PBMs) provide as critical partners in providing affordable, high-quality health care benefits for their employees. Business leaders from across the country are voicing their concerns with misguided proposals targeting
A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127), which fundamentally misconstrues the role of pharmacy benefit companies, unfairly proposes to take away employers’
In case you missed it, the Competitive Enterprise Institute (CEI) released a new video, “Pharmacy Benefit Managers and Healthcare Costs: Not a Policy Paper, Just A Thought,” explaining how pharmacy benefit companies lower health care costs. Dr. Joel Zinberg, senior
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on the Administration’s listening session on PBMs. “Today’s White House listening session on PBMs, where policymakers only hear from people and groups with vocal anti-PBM agendas, will
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription drug costs for patients and health plan sponsors. PBMs administer prescription drug plans for more than 266 million Americans with
Ever-Broadening Actions Will Increase Prescription Drug Spending by Nearly $5 Billion (Nashville, TN) — The Pharmaceutical Care Management Association (PCMA) today released a report finding that recent legal changes taken in Tennessee would increase prescription drug costs for employers, health plan sponsors,
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued the following statement on a new research paper, “Ending Pay for PBM Performance: Consequences for Prescription Drug Prices, Utilization, and Government Spending,” authored by University of Chicago Professor of
In case you missed it, WTOP’s Mitchell Miller spoke with former U.S. Senator Pat Toomey (R-PA) about the current health care debate in Congress in a conversation titled; “The Political And Economic Ramifications Of Undermining The Free Market In Health
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on today’s remarks by Food and Drug Administration Commissioner Scott Gottlieb, specifically those appearing to reference drug manufacturer abuses of risk evaluation and mitigation strategies (REMS) that
©2024 PCMA. All Rights Reserved.
